Colifoam Rectal Foam
What it is used for
This product approved for registraiton as a variation of a product accepted for inclusion in the ARTG as ‘currently supplied’ at the commencement of the Act. Indications are held in ARTG paper records. Previous Product Number AUST R 15654. Product Information not reviewed. INDICATIONS AS AT 21 AUGUST 1998: Topical treatment of inflammation occurring in the rectal mucosa, eg ulcerative colitis, proctosigmoiditis and granular proctitis.
How to take it
The way to take this medicine is: Rectal. This medicine is given via the rectum.
- Store below 25 degrees Celsius
- Do not Refrigerate
- Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
How to take it
The way to take this medicine is: Rectal. This medicine is given via the rectum.
- Store below 25 degrees Celsius
- Do not Refrigerate
- Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Visual appearance
White, aerosol foam.
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on March 1, 2020. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.